RxDoctor Payments Data

Lea Jordan

Family · Loveland, OHNPI 1699292805

Payments from drug & device makers

$945in general payments, 2019–2025

Across 46 payments — averaging $20.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$197
  • Novo Nordisk$190
  • AstraZeneca$85
  • Pfizer$80
  • Abbott$76
  • AbbVie$55
  • plus $263 from 10 others

What the payments were for

  • Food & beverage$945100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$945 in reported general payments places this provider in the 70th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$15,067
Medicare patients
104
Services billed
186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban32$22,788
OzempicSemaglutide11$19,266
Lagevrio (Eua)Molnupiravir12$5,720
Qvar RedihalerBeclomethasone Dipropionate13$3,940
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$1,138
Atorvastatin Calcium125$903
Albuterol Sulfate HfaAlbuterol Sulfate46$644
Azelastine Hcl21$539
Klor-Con M20Potassium Chloride14$521
Pantoprazole Sodium53$511
Levothyroxine Sodium67$476
CefuroximeCefuroxime Axetil26$409
Losartan Potassium48$350
Metformin Hcl38$300
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst24$291

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$80$22,78832 claims
Novo NordiskOzempic$190$19,26611 claims
MerckLagevrio (Eua)$31$5,72012 claims
AbbVieSynthroid$55$13211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,812 family providers in Ohio.

Other family in Loveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →